| Proxy discrimination in the age of artificial intelligence and big data AER Prince, D Schwarcz Iowa L. Rev. 105, 1257, 2019 | 313 | 2019 |
| Shared decision-making in vascular surgery J Xu, AER Prince Journal of vascular surgery 70 (5), 1711-1715, 2019 | 86 | 2019 |
| Genetic information, non-discrimination, and privacy protections in genetic counseling practice AER Prince, MI Roche Journal of genetic counseling 23 (6), 891-902, 2014 | 64 | 2014 |
| Prevention for those who can pay: insurance reimbursement of genetic-based preventive interventions in the liminal state between health and disease AER Prince Journal of Law and the Biosciences 2 (2), 365-395, 2015 | 57 | 2015 |
| Factors which impact the delivery of genetic risk assessment services focused on inherited cancer genomics: expanding the role and reach of certified genetics professionals C Radford, A Prince, K Lewis, T Pal Journal of genetic counseling 23 (4), 522-530, 2014 | 50 | 2014 |
| When does an illness begin: genetic discrimination and disease manifestation AER Prince, BE Berkman The Journal of Law, Medicine & Ethics 40 (3), 655-664, 2012 | 46 | 2012 |
| Comprehensive Protection of Genetic Information-One Size Privacy of Property Models May Not Fit All AER Prince Brook. L. Rev. 79, 175, 2013 | 45 | 2013 |
| Addressing underrepresentation in genomics research through community engagement AA Lemke, ED Esplin, AJ Goldenberg, C Gonzaga-Jauregui, ... The American Journal of Human Genetics 109 (9), 1563-1571, 2022 | 39 | 2022 |
| Insurance risk classification in an era of genomics: is a rational discrimination policy rational? AER Prince Nebraska law review 96 (3), 624, 2017 | 38 | 2017 |
| Direct-to-consumer genetic testing and potential loopholes in protecting consumer privacy and nondiscrimination RM Hendricks-Sturrup, AER Prince, CY Lu Jama 321 (19), 1869-1870, 2019 | 33 | 2019 |
| Tantamount to Fraud: Exploring Non-Disclosure of Genetic Information in Life Insurance Applications as Grounds for Policy Rescission AER Prince Health Matrix 26, 255, 2016 | 31 | 2016 |
| Patient and provider perspectives on polygenic risk scores: implications for clinical reporting and utilization ACF Lewis, EF Perez, AER Prince, HR Flaxman, L Gomez, DG Brockman, ... Genome Medicine 14 (1), 1-16, 2022 | 30* | 2022 |
| Establishing the International genetic discrimination Observatory Y Joly, G Dalpé, C Dupras, B Bévière-Boyer, A De Paor, ES Dove, ... Nature Genetics 52 (5), 466-468, 2020 | 27 | 2020 |
| Automatic placement of genomic research results in medical records: do researchers have a duty? Should participants have a choice? AER Prince, JM Conley, AM Davis, G Lázaro-Muñoz, RJ Cadigan Journal of Law, Medicine & Ethics 43 (4), 827-842, 2015 | 27 | 2015 |
| What guidance does HIPAA offer to providers considering familial risk notification and cascade genetic testing? NB Henrikson, JK Wagner, H Hampel, C DeVore, N Shridhar, JL Williams, ... Journal of Law and the Biosciences 7 (1), lsaa071, 2020 | 23 | 2020 |
| Genomic screening of the general adult population: key concepts for assessing net benefit with systematic evidence reviews AER Prince, JS Berg, JP Evans, DE Jonas, G Henderson Genetics in Medicine 17 (6), 441-443, 2015 | 22 | 2015 |
| Reconceptualizing harms and benefits in the genomic age AER Prince, BE Berkman Personalized medicine 15 (5), 419-428, 2018 | 20 | 2018 |
| Which results to return: subjective judgments in selecting medically actionable genes G Lázaro-Muñoz, JM Conley, AM Davis, AER Prince, RJ Cadigan Genetic testing and molecular biomarkers 21 (3), 184-194, 2017 | 20 | 2017 |
| Political economy, stakeholder voices, and saliency: lessons from international policies regulating insurer use of genetic information AER Prince Journal of Law and the Biosciences 5 (3), 461-494, 2018 | 19 | 2018 |
| Is there evidence that we should screen the general population for Lynch syndrome with genetic testing? A systematic review AER Prince, RJ Cadigan, GE Henderson, JP Evans, M Adams, ... Pharmacogenomics and Personalized Medicine, 49-60, 2017 | 19 | 2017 |
